NexImmune Inc. Gains 55.88%

Tue, Jan 09, 2024 at 07:34 PM

NexImmune Inc. (NEXI:NASDAQ) shot up at $11.8, a gain of 55.9%. On Tue, Jan 09, 2024, NEXI:NASDAQ touched a New 2-Week High of $11.8. From Tue, Dec 26, 2023, the stock recorded 77.78% Up Days and 50.00% Green Days

The stock spiked on Tue, Jan 09, 2024 at $16.56 with a volume of 16M+.

About NexImmune Inc. (NEXI:NASDAQ)

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.

Top 10 Gainers:

Sentage Holdings Inc. (SNTG:NASDAQ), 62.91%
Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 60.96%
NexImmune Inc. (NEXI:NASDAQ), 55.88%
Kaspien Holdings Inc. (KSPN:NASDAQ), 48.89%
Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ), 48.14%
Galera Therapeutics, Inc. (GRTX:NASDAQ), 41.42%
Solid Biosciences Inc. (SLDB:NASDAQ), 35.29%
Cutera, Inc. (CUTR:NASDAQ), 34.65%
Leddartech Hldgs Inc Com (LDTC:NASDAQ), 34.03%
Trinity Place Holdings Inc. (TPHS:NYSEMKT), 32.73%